Anthropic IPO Excludes Subscription Orders From Institutions in Mainland China and Hong Kong
According to Bloomberg, citing people familiar with the matter, institutional investors in mainland China and Hong Kong have been excluded from the subscription range for Anthropic’s initial public offering. Some banks have refused to accept orders from the relevant investors, while others believe that even if orders were allowed to be submitted, the likelihood of ultimately receiving share allocations would be low. The restrictions are partly due to the U.S. International Traffic in Arms Regulations (ITAR). An Anthropic spokesperson declined to comment.
Anthropic plans to price the offering on November 18 and list on the Nasdaq Global Select Market the following day under the ticker symbol ANT. Goldman Sachs and Morgan Stanley are leading the offering, with about 20 other banks participating. The company is planning to raise up to about $90.4 billion through the IPO and a concurrent private placement, implying a fully diluted valuation of about $1.4 trillion. Investor subscription indications are currently about six times the number of shares available for the offering.
Some Chinese investors are still exploring other ways to participate. A family office set up by a founder of a Chinese technology company is trying to subscribe through a trust registered in the British Virgin Islands; other investors are considering using special purpose vehicles or swap agreements to participate. Hong Kong investors may also be able to submit orders through offshore holding structures, but whether they ultimately receive allocations will still be determined by the issuer, and it is expected that this will not be explicitly set out in formal written documents. This arrangement is similar to the handling of SpaceX’s IPO earlier this year, when underwriters were also asked not to accept orders from mainland China and Hong Kong, for reasons that also involved ITAR, but investors in both places could still buy in the secondary market after the listing. Anthropic’s offering documents do not explicitly list sales restrictions for investors in mainland China and Hong Kong, but the company has included U.S.-China artificial intelligence competition and other factors as business risks in the prospectus.
Original source:
Title: Anthropic IPO Share Orders From China Are Said to Be Rebuffed
Publisher: Bloomberg
Publication date: 2026-11-13
URL: bloomberg.com/news/articles/2026-11-13/anthropic-ipo-share-orders-from-china-are-said-to-be-rebuffed
Source type: media report
Verification status: Content visible on the page actually accessed in this report (2026-11-13); the full text requires a subscription, and the key facts are consistent with multiple retellings
Supporting content: Institutional investors in mainland China and Hong Kong were excluded from Anthropic IPO subscription; some banks rejected orders or believed allocation chances were low; the restrictions were partly due to ITAR; Anthropic declined to comment
ABAB AI Insight
Anthropic was founded by Dario Amodei and other former OpenAI researchers and positions itself as a safety-oriented frontier model company. Its Claude series products have not been officially offered as commercial services in mainland China or Hong Kong. The company previously publicly accused several Chinese AI labs, including DeepSeek, Moonshot, MiniMax and Alibaba, of using fake accounts to massively “distill” Claude outputs to train their own models; related reports said this involved tens of millions of interactions. Anthropic has updated its supported-region policy to prohibit entities controlled or registered in China from using its services, and it lists U.S.-China AI competition as a risk factor in the prospectus.
This IPO subscription restriction is not an explicit ban written into the prospectus, but is being implemented through verbal or internal guidance from the underwriting syndicate, and some banks are directly rejecting orders. The concurrent private placement of about $26 billion is aimed at technology partners including Google, Nvidia and TSMC, at the IPO price. Subscription indications are about six times oversubscribed, indicating that demand is concentrated among institutional investors in other regions. Chinese investors are attempting to participate through offshore structures such as BVI trusts, SPVs or swaps, while the final allocation authority remains with the issuer.
Compared with SpaceX’s roughly $75 billion IPO earlier this year, both cases excluded mainland China and Hong Kong orders on ITAR grounds; SpaceX, as a defense-related technology company, had its website and materials blocked in both places, while Anthropic reflects a situation in which AI models may under certain scenarios be subject to export controls. SpaceX investors could buy in the secondary market after listing, and Anthropic is expected to be similar. The difference is that Anthropic’s prospectus does not separately specify regional sales prohibitions, and its risk disclosures focus more on model distillation and U.S.-China competition rather than rocket and satellite hardware.
This arrangement further separates Anthropic’s shareholder base at the primary-market stage from Chinese capital, reinforcing its compliance positioning as a U.S. strategic AI asset while potentially narrowing direct participation channels for some Asian capital. For Anthropic, the oversubscribed status indicates that demand from other regions is sufficient to cover the offering size; for China-related investors, the success rate of offshore structures depends on the issuer’s final allocation decision. Indicators to watch include whether known China-linked entities appear in the actual allocation list after pricing, and the scale of capital inflows from both places through the secondary market after the listing.
ABAB News · Cognitive Law
Export controls can extend from product sales to primary-market allocations without having to be written into the prospectus as explicit terms.
Regional exclusion in an oversubscribed offering reflects compliance taking precedence over maximizing order coverage.
Offshore structures can attempt to bypass direct order rejection, but final allocation still rests with the issuer.